Overcoming Stumbling Blocks with Digitalization Best Practices
Digital transformation in the biopharma industry can streamline manufacturing and help shorten time-to-market. However, adoption of digital technologies in the biopharma industry has been slow. Below are a few “best practice” recommendations to help biopharma companies overcome stumbling blocks to digitalization technology adoption:
- Ensure data fusion: from electronic batch records in production to laboratory information management systems (LIMS) in the laboratory to enterprise resource planning (ERP) for inventory, it is essential to ensure an open architecture system that allows the seamless sharing of data between every technology. This will create a data ecosystem with the potential to serve as a digital treasure map of information.
- Do not get lost in data, but do not lose what you do not use: biopharma manufacturing can produce an overwhelming amount of data, and it can be tempting to analyze all of these data to guide decision making. Smart analytics and cloud computing provide the capability to determine which data are relevant for a specific process and where there is opportunity for improvement. Consider also that data which are unused now could potentially play a role in future optimization or innovation.
- Outline and understand security limitations and data privacy: avoid potentially significant disruptions or compliance issues by spending time early in the adoption process to mitigate security limitations and data privacy issues. A first step is ensuring all relevant information technology team members are involved in new digitalization technology adoption and integration.
- Collaborate with experienced digitalization partners: partners, either a business or individuals who excel in their industry or subject matter area, can help provide guidance with their expertise and their technology.